HLX316

· Shanghai Henlius Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HLX316, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Clinical Study of HLX316 in Participants With Advanced/Metastatic Solid Tumors [Phase 1]